Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Fundação Oswaldo Cruz has 2 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are distributed across 2 distinct examiners and 2 distinct art units. This distribution means that each pending action is being handled by a different examiner in a different specialized unit. This variety suggests that the company's current applications cover distinct technical grounds within the broader biotechnology field.
The busiest examiner, HINES, JANA A, is responsible for 1 pending office action. This matches the workload of the other distinct examiner involved in the portfolio, resulting in an even split of the 2 pending office actions. The involvement of 2 distinct art units for only 2 pending office actions indicates that the subject matter is diverse enough to require different technical expertise. For a practitioner, this means that the prosecution of each action will be governed by the specific standards of 2 distinct art units and the individual preferences of 2 distinct examiners.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HINES, JANA A | 1 | 53.0% | +39.7% |
| YIP, JACK | 1 | 33.0% | +37.8% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18574262 | Veterinary Vaccine Composition Against Parasitic Worms, Method for Treating and Preventing Infection by Parasitic Worms, and Use | HINES, JANA A | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17794646 | RAT BIOMODELS FOR TRAINING IN MEDICAL CRANIOTOMY TECHNIQUES | YIP, JACK | 23d overdue |
| 18574262 | Veterinary Vaccine Composition Against Parasitic Worms, Method for Treating and Preventing Infection by Parasitic Worms, and Use | HINES, JANA A | — |
| Art Unit | Apps |
|---|---|
| 1645 | 1 |
| 3715 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18574262 | Veterinary Vaccine Composition Against Parasitic Worms, Method for Treating and Preventing Infection by Parasitic Worms, and Use | HINES, JANA A | 1645 | §103§112 | Final Rejection | — | Pending | Dec 26, 2023 |
| 17794646 | RAT BIOMODELS FOR TRAINING IN MEDICAL CRANIOTOMY TECHNIQUES | YIP, JACK | 3715 | §103 | Non-Final OA | 23d overdue | Pending | Jul 22, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial